Related Experiment Video
Updated: Feb 20, 2026
An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
Published on: July 20, 2014
Scaffold Proteins in Gastrointestinal Tumors as a Shortcut to Oncoprotein Activation
Chushu Li1, Huanbin Wang1, Han Yao1
1Division of Gastroenterology and Hepatology, Renji Hospital School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Background:
The development of cancer involves uncontrolled cell proliferation, and multiple signaling pathways that regulate cell proliferation have been found to be dysregulated in cancers. Extracellular signal-regulated protein kinase (ERK) is one of three major subtypes in the mitogen-activated protein kinase (MAPK) families. The MAPK/ERK pathway (RAS/RAF1/MEK/ERK) plays an important part in promoting cell proliferation in response to growth factors, thereby serving as a driving signal in gastrointestinal (GI) tumors. In contrast, the p53 tumor suppressor functions as a "guardian of the genome" and stops cell proliferation when oncogenic signaling is activated.
Summary:
Both pathways constrain each other in healthy GI epithelium, facilitating controlled proliferation that is essential for tissue repair and regeneration. However, in GI tumors, the MAPK/ERK and p53 pathways are commonly dysregulated, in part due to abnormal posttranslational modifications. Hyperphosphorylation of the ERK protein causes sustained activation of cell proliferation, whereas hypoacetylation of the p53 protein impairs its transcriptional function and blocks cell apoptosis. Multiple scaffold proteins have been found to regulate the posttranslational modifications of ERK and p53 proteins in GI tumors.
Key Message:
Abnormal expression of scaffold proteins may contribute to the dysregulation of the MAPK and p53 signaling pathways and thereby contribute to the development of GI tumors.
Practical Implications:
Scaffold proteins are potential biomarkers and therapeutic targets in GI tumors.
Insights
Scaffold proteins regulate cell proliferation pathways in gastrointestinal (GI) tumors. Dysregulation of these proteins contributes to cancer development and offers potential therapeutic targets.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- Cancer involves uncontrolled cell proliferation driven by dysregulated signaling pathways like MAPK/ERK.
- The p53 tumor suppressor normally halts proliferation but is impaired in cancers.
- Both pathways are crucial for controlled proliferation in healthy gastrointestinal (GI) epithelium.
Purpose of the Study:
- To investigate the role of scaffold proteins in the dysregulation of MAPK/ERK and p53 pathways in GI tumors.
- To explore scaffold proteins as potential biomarkers and therapeutic targets for GI cancers.
Main Methods:
- Analysis of posttranslational modifications of ERK and p53 proteins.
- Investigation of the regulatory roles of scaffold proteins in these modifications.
- Examination of pathway crosstalk in healthy and cancerous GI tissues.
Main Results:
- Dysregulation of MAPK/ERK and p53 pathways in GI tumors is linked to abnormal posttranslational modifications.
- Hyperphosphorylation of ERK promotes sustained cell proliferation.
- Hypoacetylation of p53 impairs its tumor-suppressive functions, including apoptosis.
Conclusions:
- Scaffold proteins play a critical role in regulating the posttranslational modifications of ERK and p53.
- Abnormal scaffold protein expression contributes to GI tumor development by disrupting these key pathways.
- Scaffold proteins represent promising biomarkers and therapeutic targets for GI cancers.
Related Concept Videos
03:03mTOR Signaling and Cancer Progression
The mTOR pathway or the...
01:30Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
01:33Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:07MAPK Signaling Cascades
01:19Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
01:22PI3K/mTOR/AKT Signaling Pathway